This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Symmetry Medical Reports Fourth Quarter And Full Year 2012 Financial Results

Provides 2013 Financial Guidance

Fourth Quarter Highlights:

  • Revenue of $106.6 million, up 26% year-over-year
  • Gross margin of 27.1% compared to 16.4% year ago
  • Operating income of $8.7 million; as adjusted operating income of $13.7 million, up 403% year-over-year
  • Net income of $2.9 million; as adjusted net income of $6.1 million, up 371% year-over-year
  • Generated strong cash from operations of $10.7 million
  • Continued debt reduction; leverage ratio at 3.3

WARSAW, Ind., Feb. 21, 2013 (GLOBE NEWSWIRE) -- Symmetry Medical Inc. (NYSE:SMA), a leading global source of innovative medical device solutions, including surgical instruments, orthopedic implants, and sterilization cases and trays, announced fourth quarter and full year 2012 financial results for the period ended December 29, 2012.

  Fourth Quarter Vs Prior Quarter Total Year
(in millions, except per share data) 2012 2011 Change 4Q'12 3Q'12 Change 2012 2011 Change
Revenue  $ 106.6  $ 84.5 26%  $ 106.6  $ 100.9 6%  $ 410.5  $ 359.0 14%
Operating income  8.7  (4.1) FAV  8.7  10.2 -15%  33.0  8.3 300%
Net income  2.9  (3.2) FAV  2.9  3.7 -22%  9.1  2.9 216%
EPS  $ 0.08  $ (0.09) FAV  $ 0.08  $ 0.10 -20%  $ 0.25  $ 0.08 213%
                   
As Adjusted Non-GAAP*                  
Operating income*  $ 13.7  $ 2.7 403%  $ 13.7  $ 14.0 -2%  $ 49.7  $ 24.3 104%
Net income*  6.1  1.3 371%  6.1  6.5 -6%  20.7  13.6 53%
EPS*  $ 0.17  $ 0.04 340%  $ 0.17  $ 0.18 -6%  $ 0.57  $ 0.38 51%
                   
* Excludes non-cash charges for stock compensation expense, amortization of intangible assets and debt issuance costs, impairment of an intangible asset in 2011, as well as charges for management transition costs, acquisition related costs, facility closure and severance, SEC related legal costs and legal entity restructuring costs. See "As Adjusted Financial Measures" below.
       
       
(in millions, except per share data) Fourth Quarter Vs Prior Quarter Total Year
Revenue by Product: by Segment 2012 2011 Change 4Q'12 3Q'12 Change 2012 2011 Change
OEM Solutions Revenue                  
Instruments  $ 30.0  $ 27.3 10%  $ 30.0  $ 29.6 1%  $ 115.2  $ 115.3 0%
Implants  26.5  22.9 16%  26.5  25.6 3%  102.0  103.3 -1%
Cases  13.9  15.9 -12%  13.9  14.2 -2%  58.5  75.8 -23%
Other  7.7  7.2 8%  7.7  6.7 16%  27.6  25.1 10%
Total OEM Solutions Revenue  $ 78.1  $ 73.3 7%  $ 78.1  $ 76.1 3%  $ 303.3  $ 319.5 -5%
Symmetry Surgical Revenue  28.5  11.2 154%  28.5  24.8 15%  107.2  39.5 172%
                   
Total Revenue  $ 106.6  $ 84.5 26%  $ 106.6  $ 100.9 6%  $ 410.5  $ 359.0 14%

Revenue for the fourth quarter 2012 was $106.6 million, up 26.1% compared to $84.5 million in the same period last year. The year-over-year revenue increase was driven by growth in the Company's OEM Solutions and Symmetry Surgical segments. Symmetry Surgical segment results for the fourth quarter 2012 included the Company's December 2011 acquisition of the surgical instruments business of Codman & Shurtleff, Inc.

1 of 6

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 18,080.14 +21.45 0.12%
S&P 500 2,117.69 +4.76 0.23%
NASDAQ 5,092.0850 +36.0220 0.71%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs